Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Drugs Dermatol ; 20(8): 898-900, 2021 Aug 01.
Article in English | MEDLINE | ID: covidwho-1359539

ABSTRACT

Vaccination is an important intervention in preventing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Messenger RNA (mRNA) vaccines from Pfizer™ and Moderna™ are the first to market in the United States, and while cutaneous adverse events have been reported in clinical trials for both of these vaccines, they have not been well characterized. Here we report a case of a patient who developed herpes zoster after receiving the Moderna™ COVID-19 vaccine. Dermatologists should familiarize themselves with this and other potential cutaneous adverse events associated with COVID-19 vaccination. J Drugs Dermatol. 2021;20(8):898-900. doi:10.36849/JDD.6146.


Subject(s)
COVID-19 Vaccines/adverse effects , COVID-19 , Herpes Zoster , Vaccination , COVID-19/prevention & control , Herpes Zoster/chemically induced , Herpes Zoster/diagnosis , Humans , United States , Vaccination/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL